MedPath

Investigation of the Effect of Information on the Empowerment of Cancer Patients Using Question Prompt List: a Mixed Method Study

Not Applicable
Active, not recruiting
Conditions
Neoplasms (Cancer / Tumors)
Patient Participation
Health Communication
Patient-Centered Care
Patient Empowerment
Anxiety
Registration Number
NCT06903390
Lead Sponsor
Marmara University
Brief Summary

Brief Summary The goal of this study is to understand how patient empowerment and a Question Prompt List (QPL) can help cancer patients.

The main questions this study aims to answer are:

What are the views of nurses, physicians, and cancer patients on patient empowerment? Does using a Question Prompt List (QPL) improve patient empowerment and reduce anxiety? Researchers will collect qualitative and quantitative data by measuring patient empowerment and anxiety levels.

Who can participate? Cancer patients receiving treatment at Private Anadolu Medical Center Hospital Nurses and physicians working with cancer patients What will participants do? Answer survey questions about their experiences with empowerment, anxiety, and communication Participate in interviews to share their thoughts on patient empowerment Use a Question Prompt List (QPL) during medical consultations Why is this study important? Many cancer patients struggle with anxiety and lack of information about their care.

A Question Prompt List (QPL) may help patients ask better questions, feel more in control of their treatment, and reduce anxiety.

This study will contribute to oncology research and help develop a culture-specific QPL for use in cancer care.

This study will take place at Private Anadolu Medical Center Hospital from January 2023 to November 2024.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
96
Inclusion Criteria
  • Patients must be over 18 years old.
  • Must understand and speak Turkish.
  • Must not have any condition preventing participation (e.g., advanced dementia, cognitive impairment, speech or hearing disorders).
  • For healthcare professionals in the qualitative phase: Must have at least one year of experience in oncology.
Exclusion Criteria
  • Patients without regular outpatient follow-up visits.
  • Patients with severe cognitive or physiological deterioration affecting participation.
  • Patients who do not comply with the study process and requirements.
  • Patients who voluntarily request to withdraw from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Patient Empowerment ScoreImmediately before the first consultation and within 1 day after the second and third consultations

Assessed using the Patient Empowerment Scale to evaluate the effect of QPL-based communication on patient empowerment compared to standard communication. Higher scores indicate greater empowerment.

Change in Anxiety Level (HADS)Immediately before the first consultation and within 1 day after the second and third consultations

Measured using the Hospital Anxiety and Depression Scale (HADS) to assess changes in anxiety levels resulting from QPL-based communication versus standard communication. Lower scores indicate lower anxiety.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Marmara Üniversitesi

🇹🇷

İstanbul, Kadıköy, Turkey

© Copyright 2025. All Rights Reserved by MedPath